Filling the gaps in COPD: the TRIBUTE study
- PMID: 29429594
- DOI: 10.1016/S0140-6736(18)30252-6
Filling the gaps in COPD: the TRIBUTE study
Erratum in
-
Department of Error.Lancet. 2018 Mar 17;391(10125):1022. doi: 10.1016/S0140-6736(18)30318-0. Epub 2018 Feb 14. Lancet. 2018. PMID: 29454593 No abstract available.
Comment on
-
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
Similar articles
-
Airflow obstruction and left ventricular filling pressure in suspected chronic obstructive pulmonary disease.Respir Physiol Neurobiol. 2014 Feb 1;192:85-9. doi: 10.1016/j.resp.2013.12.008. Epub 2013 Dec 19. Respir Physiol Neurobiol. 2014. PMID: 24361463
-
Early Detection of Chronic Obstructive Pulmonary Disease in Apparently Healthy Attendants of Tertiary Care Hospital and Assessment of its Severity.J Coll Physicians Surg Pak. 2017 May;27(5):296-300. J Coll Physicians Surg Pak. 2017. PMID: 28599692
-
Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement.Qual Prim Care. 2012;20(5):365-73. Qual Prim Care. 2012. PMID: 23114004 Review.
-
Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients.Am J Geriatr Pharmacother. 2012 Apr;10(2):110-122.e1. doi: 10.1016/j.amjopharm.2011.12.003. Epub 2012 Jan 26. Am J Geriatr Pharmacother. 2012. PMID: 22280978
-
What does endotyping mean for treatment in chronic obstructive pulmonary disease?Lancet. 2017 Sep 2;390(10098):980-987. doi: 10.1016/S0140-6736(17)32136-0. Lancet. 2017. PMID: 28872030 Review.
Cited by
-
Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives.Adv Ther. 2019 Mar;36(3):495-519. doi: 10.1007/s12325-019-0893-3. Epub 2019 Feb 11. Adv Ther. 2019. PMID: 30742242 Free PMC article.
-
Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:249-260. doi: 10.2147/COPD.S185485. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30718952 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical